NCT01773798
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Graz, Austria
Clinical trial condition
Diabetes Mellitus, Type 1
Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.
881 public trials
62 recruiting studies
Diabetes Mellitus, Type 1 trial results
NCT01469143
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Neuss, Germany
Completed
A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes
NCT01455142
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Graz, Austria
NCT01296438
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Neuss, Germany
Completed
A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) Patients
NCT01337141
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Hospital Clínic de Barcelona Barcelona, Spain
- Hospital Clínico de Madrid Madrid, Spain
- Hospital de Cruces Barakaldo, Spain
- Hospital Carlos Haya Málaga, Spain
NCT00592072
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Yale University School of Medicine New Haven, Connecticut, United States
NCT00542620
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Paris, France
Completed
A Study in Adults With Type 1 Diabetes
NCT01421147
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hollywood, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Port Richey, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. West Palm Beach, Florida, United States
NCT01600950
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany
Completed
Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (Italy)
NCT01727817
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- University of Padova Padova, Italy